Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alexion Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
PNH \> 6 months
Type III PNH red blood cell (RBC) clone by flow cytometry \>10%
At least one transfusion in the past 2 years but no more than 3 transfusions in the past 12 months; or personal beliefs that preclude the use of transfusion with severe hemolytic PNH
Lactate dehydrogenase (LDH) \>1.5 x upper limit of normal
Must avoid conception
Willing and able to give written informed consent
You may not be if
Platelet count of \<30,000/mm3
Absolute neutrophil count \<500/ul
Active bacterial infection
Hereditary complement deficiency
History of bone marrow transplantation
Participation in any other investigational drug trial or exposure to other investigational agent, device or procedure within 30 days
Pregnant, breast-feeding, or intending to conceive